Biologics in Refractory Vasculitis
Conditions: Giant Cell Arteritis; Takayasu Arteritis; Cogan Syndrome; Relapsing Polychondritis; Cryoglobulinemic Vasculitis; IgA Vasculitis; Polyarteritis Nodosa; Cutaneous Polyarteritis Nodosa; Primary Angiitis of Central Nervous System Interventions: Biological: Rituximab; Biological: Infliximab; Biological: Tocilizumab Sponsor: Cambridge University Hospitals NHS Foundation Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Cambridge University | Foundation Trusts | Hospitals | Polychondritis | Remicade | Research | Rituxan | Vasculitis